Baudax Bio share price logo

Baudax Bio

OTC: BXRXQ

Live

as on

Baudax Bio Stock Performance

as on October 17, 2026 at 2:08 am IST

Baudax Bio share price movements today

Previous Close
-
Open
-
Volume
7.0K
Market Cap
$436.0

Baudax Bio Historical Returns

1 Month Return
0 %
3 Month Return
0 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Baudax Bio Stock Fundamentals & Key Indicators

Check Baudax Bio market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$436.0

EPS (TTM)

-9.23

Dividend Yield

0.00%

PE Ratio (TTM)

0

Industry PE ratio

0.00

PEG Ratio

0.00

Return On Equity TTM

1067.45%

Baudax Bio stock Key Stats

Compare market cap, revenue, PE, and other key metrics of Baudax Bio with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Baudax Bio image
Baudax Bio
NA$436.0NANA-452.32%0.00%

Baudax Bio Quarterly Profit & Loss

All numbers in Millions USD

Jun 2021
Sep 2021
Dec 2021
Mar 2022
Jun 2022
Sep 2022
Dec 2022
Mar 2023
Jun 2023
Sep 2023
Total Revenue
0
0
0
0
0
0
0
-
-
-
Gross Profit
0
0
0
0
0
0
-4
0
0
0
Operating Income
-16
-16
30
-7
-3
-3
-8
-4
-7
-1
EBITDA
-11
-11
22
-6
-3
-28
-7
-4
-4
-5
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-15
-16
29
-8
-4
-4
-9
-7
-7
-1
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-15
-16
29
-12
-7
-29
-9
11
-7
-1
Net Profit Margin
-191.54%
-64.41%
-44.00%
-53.55%
-20.33%
-407.56%
-1445.81%
0.00%
0.00%
0.00%

Baudax Bio Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Total Revenue
-
-
-
0
1
1
Gross Profit
-
-
-
-1
-1
-5
Operating Income
-61
-73
-32
-74
-19
-56
EBITDA
-48
-64
-32
-72
-49
-33
Interest Expense
-
-
-
1
2
-
Depreciation
0
0
0
2
2
2
Income Before Tax
-61
-73
-32
-76
-19
-58
Income Tax Expense
-
-
-
-
-
-
Net Income
-61
-73
-32
-76
-19
-58
Net Profit Margin
0.00%
0.00%
0.00%
-251.32%
-126.39%
-452.32%

Baudax Bio Quarterly Cash Flow

All numbers in Millions USD

Jun 2021
Sep 2021
Dec 2021
Mar 2022
Jun 2022
Sep 2022
Dec 2022
Mar 2023
Jun 2023
Sep 2023
Net Income
-15
-16
29
-12
-4
-4
-9
-7
-7
-1
Operating Cash Flow
-10
-12
-12
-12
-7
-3
-3
-4
-3
-2
Investing Cash Flow
-4
2
10
0
-
0
-
-
0
0
Financing Cash Flow
9
0
3
8
0
4
3
3
0
1
Change in Cash
-5
-10
1
-4
-6
0
0
-1
-2
-1

Baudax Bio Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Net Income
-61
-73
-32
-76
-19
-58
Operating Cash Flow
-43
-59
-50
-44
-49
-27
Investing Cash Flow
-1
-3
-1
0
0
0
Financing Cash Flow
44
63
69
57
35
17
Change in Cash
-
-
17
12
-14
-10

About Baudax Bio

Baudax Bio, Inc., a biotechnology company, develops and commercializes products for hospital and other acute care related settings. The company develops T cell receptor, that focus on immune modulating therapies for orphan diseases or complications associated with such diseases, as well as the treatment of autoimmune disorders. It also develops BX1000, an intermediate-acting neuromuscular blocking agent (NMB) that is in phase II clinical trial; BX2000, an ultra- short acting NMB, which is in phase I clinical trial, as well as a proprietary blockade reversal agent; and BX3000, a NMB reversal agent that is in preclinical studies. Baudax Bio, Inc. was incorporated in 2015 and is based in Malvern, Pennsylvania. On February 22, 2024, Baudax Bio, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Eastern District of Pennsylvania.
OrganisationBaudax Bio
Headquarters490 Lapp Road, Malvern, PA, 19355, US
IndustryBiotechnology
CEOGerri Henwood

Key Management of Baudax Bio

Name

Title

Dr. Geraldine A. Henwood Ph.D.

President, CEO & Director

Mike Choi

Vice President of Financial Planning & Analysis

Ms. Natalie McAndrew

Consultant & Principle Accounting Officer

Dr. Chan Kim Yong Ph.D.

Chief Scientific Officer & Director

FAQs

What is Baudax Bio's market capitalisation today?

Baudax Bio market capitalisation is $0.00T as on .

How to invest in Baudax Bio Stock (BXRXQ) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Baudax Bio on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Baudax Bio Stock (BXRXQ) from India?

Indian investors can start investing in Baudax Bio (BXRXQ) shares with as little as ₹94.94000244140625 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.40 in Baudax Bio stock (as per the Rupee-Dollar exchange rate as on ). Learn more about fractional shares .